Australia

INOVIQ's SubB2M/CA15-3 Breast Cancer Test Shows Excellent Clinical Data

INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) The...

 June 28, 2023 | News

SK bioscience and the Peter Doherty Institute for Infection and Immunity Join Forces Against Influenza

SK bioscience will collaborate with one of the world’s leading biomedical research institutes, the Peter Doherty Institute for Infection and Immunity...

 June 27, 2023 | News

Psylo Partners with Daiichi Sankyo for Non-Hallucinogenic Psychiatric Therapies

Biotech start-up, Psylo, announced  that it has entered into a Sponsored Research Agreement with global Japanese pharmaceutical company, Daiichi ...

 June 23, 2023 | News

Telix to Present ZIRCON Phase III Kidney Cancer Imaging Data at SNMMI

Further data from Telix's completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (Clinic...

 June 23, 2023 | News

Telix to Expand Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical

SENSEI is an ultra-miniature robotic gamma probe for intracavital use that is able to provide radiopharmaceutical-based surgical guidance ("radio-guided su...

 June 22, 2023 | News

"Jumar Bioincubator" calls for next-gen biotechs, appoints new GM

The "Jumar Bioincubator" will be supported by cash and in-kind contributions of approximately $45 million over ten years from its founding partne...

 June 22, 2023 | News

Aravax doses first patient in Phase 2 peanut allergy clinical trials

Allergy clinical trial centres across Victoria, South Australia, New South Wales, and Western Australia have invited children and ...

 June 02, 2023 | News

Avance Clinical at ASCO & BIO 2023: Rising Complexity and Patient Demand in Early Phase Oncology Trials

  According to Avance Clinical's Chief Scientific Officer Gabriel Kremmidiotis who is part of the Avance Clinical team attending ASCO:"Recently, Phas...

 June 02, 2023 | News

Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers

87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...

 June 01, 2023 | News

Sun Pharma and Philogen Sign Exclusive Agreement for NIDLEGY™ Commercialization in Europe, Australia, and New Zealand

Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...

 May 31, 2023 | News

AMP945 and FOLFIRINOX Synergize for Enhanced Pancreatic Cancer Treatment

  Amplia's highly selective FAK inhibitor AMP945, when used in combination with FOLFIRINOX, enhances survival in a preclinical model of pancreatic ...

 May 30, 2023 | News

FivepHusion partners with Treehill Partners and Syneos Health for strategic collaboration

FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, a New York-based strategic an...

 May 29, 2023 | News

Avance Clinical Joins Global Heath Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies

Avance Clinical CEO, Yvonne Lungershausen, Chief Scientific Officer Gabriel Kremmidiotis, and Head of Scientific and Regulatory Affairs Jorgen Mould are in...

 May 25, 2023 | News

Australia's First End-to-End mRNA CDMO Facility to Boost Vaccine Production and Research Capabilities

What is the significance of the first end-to-end mRNA process contract development and manufacturing organization (CDMO) establishment in Australia?  ...

 May 17, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close